DIGIRAD CORPORATION (NASDAQ:DRAD) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b)
On October 12, 2018, Charles M. Gillman, a member of the Board of Directors (the “Board”) of Digirad Corporation (the “Company”), notified the Company of his decision to resign from the Board, effective immediately. Mr. Gillman indicated that his decision to resign was made in order to focus his time on other activities and was not the result of any disagreements with the Company or any person affiliated with the Company.
At the time of Mr. Gillman’s resignation, he was a member of the Corporate Governance and Strategic Advisory Committees of the Board.
About DIGIRAD CORPORATION (NASDAQ:DRAD)
Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services. It also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment. The Company sells solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provides service on the products it sells through its Diagnostic Imaging business segment. Diagnostic Services also offers remote cardiac event monitoring services, which include provision of a monitor, remote monitoring by registered nurses and monitoring support for its patients and physician customers. Its nuclear cameras feature detectors based on solid-state technology. Its cameras are used in hospitals, imaging centers, physician offices, and by mobile service providers.